Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Increased sleep fragmentation in experimental autoimmune encephalomyelitis.
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló's Concentric Lesions.
The epidemiology of alcohol consumption and multiple sclerosis: a review.
The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient.
Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.
Genetically Modified Pig Models for Neurodegenerative Disorders.
Interferon-beta-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report.
Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.
Psychometric properties of quality of life and health-related quality of life assessments in people with multiple sclerosis.
Altered functional connectivity and performance variability in relapsing-remitting multiple sclerosis.
Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran.
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.
Evaluation of Multi-Atlas Label Fusion for In Vivo MRI Orbital Segmentation.
Autoantibodies in neuroimmunological diseases; relevance of fine specificity.
Stability of intraindividual variability as a marker of neurologic dysfunction in relapsing remitting multiple sclerosis.
[Multimodal complex treatment in advanced multiple sclerosis.]
Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders.
Olfactory dysfunction in patients with neuromyelitis optica.
[NMO spectrum disorder].
Erythropoietin Levels in Patients with Multiple SclerosisComplicated with Anemia.
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.
The Development of Prophylactic and Therapeutic EBV Vaccines.
MS patients must have access to the best treatment options.
Translating CESD-20 and PHQ-9 Scores to PROMIS Depression.

Pages